small molecule

AVEED

TESTOSTERONE UNDECANOATE

Loss of exclusivityMay 2027latest FDA-listed patent expiry
CompanyENDO OPERATIONS LTD

Drug detail

Brand nameAVEED
Active ingredientTESTOSTERONE UNDECANOATE
Strength750MG/3ML (250MG/ML)
Dosage formINJECTABLE
RouteINTRAMUSCULAR
ModalitySmall molecule
FDA approvalMarch 2014
Marketing statusRX

Listed patents

PatentExpiresType
8338395May 2027use U-1500
7718640March 2027product

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.

AVEED patent cliff — loss of exclusivity May 2027 | CliffBio